Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Standard Chemical & Pharmaceutical Co., Ltd. (1720:TWSE), powered by AI.
Standard Chemical & Pharmaceutical Co., Ltd. is currently trading at $62.70. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Standard Chemical & Pharmaceutical Co., Ltd. on Alpha Lenz.
View Standard Chemical & Pharmaceutical Co., Ltd.'s valuation metrics on Alpha Lenz.
“Standard Chemical & Pharmaceutical Co., Ltd.'s ROE is 15.4%. Explore profitability and growth together.”
Ask for details →Standard Chemical & Pharmaceutical Co., Ltd. is a pivotal player within the pharmaceutical industry, focused on the development, manufacturing, and distribution of a wide array of pharmaceutical products. Established with a commitment to improving health outcomes, the company produces both active pharmaceutical ingredients (APIs) and finished dosage forms, ensuring a comprehensive approach to healthcare delivery. Notably, its product portfolio spans critical therapeutic areas such as cardiovascular, gastrointestinal, and anti-infective medicines, which are essential to global health management. Beyond its pharmaceutical production, Standard Chemical & Pharmaceutical Co., Ltd. adheres to rigorous quality control standards and embraces sustainable practices, reflecting its dedication to both innovation and environmental stewardship. The company's strategic presence in the market underscores its role in supporting healthcare systems across various regions, contributing to the availability of essential medications. By leveraging advanced research and development capabilities, Standard Chemical & Pharmaceutical Co., Ltd. strives to meet the dynamic demands of the pharmaceutical landscape, positioning itself as a key player in enhancing therapeutic access and efficacy worldwide.
“Standard Chemical & Pharmaceutical Co., Ltd.'s ROE is 15.4%. Explore profitability and growth together.”
Ask for details →Standard Chemical & Pharmaceutical Co., Ltd. (ticker: 1720) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
The current price is 62.7 with a P/E ratio of -x and P/B of -x.
ROE is 15.42% and operating margin is 19.37%. Annual revenue is $7.0B.